Alkermes plc
USD51.72
-1.00 (-1.90%)
CEO
Richard F. Pops
IPO Date
1991-07-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IE
Open
$52.96
Prev. Close
$52.72
Day Low
$51.70
Day High
$53.15
52W Low
$25.17
52W High
$55.67
Market Cap
$8.62B
Volume
0.94M
| 5,000 |
| $19.34 |
| 1 Jul 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | S-Sale | Disposed | 8,300 | $51.46 |
| 1 Jul 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | S-Sale | Disposed | 700 | $52.13 |
| 1 Jul 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | M-Exempt | Disposed | 5,000 | $19.34 |
| 12 Jun 2026 | Wright Christopher I | director | S-Sale | Disposed | 2,000 | $45.10 |
| 4 Jun 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | S-Sale | Disposed | 2,034 | $43.05 |
| 1 Jun 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | M-Exempt | Acquired | 5,000 | $19.34 |
| 1 Jun 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | S-Sale | Disposed | 9,000 | $41.67 |
| 1 Jun 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | M-Exempt | Disposed | 5,000 | $19.34 |